A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Cristian,Lolli

第一单位： Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. Electronic address: cristian.lolli@irst.emr.it.

作者： Cristian,Lolli ^[1] ; Amelia,Altavilla ^[2] ; Vincenza,Conteduca ^[2] ; Alberto,Farolfi ^[2] ; Chiara,Casadei ^[2] ; Giuseppe,Schepisi ^[2] ; Giuseppe Luigi,Banna ^[3] ; Ugo,De Giorgi ^[2]

作者单位： Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. Electronic address: cristian.lolli@irst.emr.it. ^[1] Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. ^[2] Department of Medical Oncology, United Lincolnshire Hospitals NHS Trust, Lincoln, United Kingdom. ^[3]

关键词 Elderly patients Immune checkpoint inhibitors Renal cell carcinoma

主题词老年人(Aged);癌, 肾细胞(Carcinoma, Renal Cell);人类(Humans);肾肿瘤(Kidney Neoplasms)

DOI 10.1016/j.critrevonc.2020.103036

PMID 32650216

发布时间 2020-09-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交